多嚢胞性卵巣症候群（PCOS）治療薬のグローバル市場調査 2019年

• 英文タイトル：Global Polycystic Ovary Syndrome (PCOS) Drugs Market Professional Survey Report 2019

• レポートコード：QYR9NV10204
• 出版社/出版日：QYResearch / 2019年11月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥518,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,036,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要
・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析
・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別）
（経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）
・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（用途別）
（病院、クリニック）
・多嚢胞性卵巣症候群（PCOS）治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Sanofi、Novartis AG、Teva Pharmaceutical Industries Limited、Addex Therapeutics Ltd.、BIOCAD、Merck KGaA、AstraZeneca plc.、Bristol Myers Squibb Co.、Ferring Pharmaceuticals, Inc.、Crinetics Pharmaceuticals, Inc.、）
・多嚢胞性卵巣症候群（PCOS）治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Polycystic Ovary Syndrome (PCOS) Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sanofi
Novartis AG
Teva Pharmaceutical Industries Limited
Addex Therapeutics Ltd.
BIOCAD
Merck KGaA
AstraZeneca plc.
Bristol Myers Squibb Co.
Ferring Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral Contraceptives
Antiandrogens
Insulin-sensitizing Agent
Antidepressant
Anti-obesity

Segment by Application
Hospital
Clinic

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Polycystic Ovary Syndrome (PCOS) Drugs
1.1 Definition of Polycystic Ovary Syndrome (PCOS) Drugs
1.2 Polycystic Ovary Syndrome (PCOS) Drugs Segment by Type
1.2.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral Contraceptives
1.2.3 Antiandrogens
1.2.4 Insulin-sensitizing Agent
1.2.5 Antidepressant
1.2.6 Anti-obesity
1.3 Polycystic Ovary Syndrome (PCOS) Drugs Segment by Applications
1.3.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Polycystic Ovary Syndrome (PCOS) Drugs Overall Market
1.4.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue (2014-2025)
1.4.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Production (2014-2025)
1.4.3 North America Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.4 Europe Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.5 China Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.6 Japan Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.8 India Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Polycystic Ovary Syndrome (PCOS) Drugs
2.3 Manufacturing Process Analysis of Polycystic Ovary Syndrome (PCOS) Drugs
2.4 Industry Chain Structure of Polycystic Ovary Syndrome (PCOS) Drugs

3 Development and Manufacturing Plants Analysis of Polycystic Ovary Syndrome (PCOS) Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Polycystic Ovary Syndrome (PCOS) Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Polycystic Ovary Syndrome (PCOS) Drugs Production and Capacity Analysis
4.2 Polycystic Ovary Syndrome (PCOS) Drugs Revenue Analysis
4.3 Polycystic Ovary Syndrome (PCOS) Drugs Price Analysis
4.4 Market Concentration Degree

5 Polycystic Ovary Syndrome (PCOS) Drugs Regional Market Analysis
5.1 Polycystic Ovary Syndrome (PCOS) Drugs Production by Regions
5.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production by Regions
5.1.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Regions
5.2 Polycystic Ovary Syndrome (PCOS) Drugs Consumption by Regions
5.3 North America Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.3.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Production
5.3.2 North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.4 Europe Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.4.1 Europe Polycystic Ovary Syndrome (PCOS) Drugs Production
5.4.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.5 China Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.5.1 China Polycystic Ovary Syndrome (PCOS) Drugs Production
5.5.2 China Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.6 Japan Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.6.1 Japan Polycystic Ovary Syndrome (PCOS) Drugs Production
5.6.2 Japan Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.7 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.7.1 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Production
5.7.2 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.8 India Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.8.1 India Polycystic Ovary Syndrome (PCOS) Drugs Production
5.8.2 India Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Polycystic Ovary Syndrome (PCOS) Drugs Import and Export

6 Polycystic Ovary Syndrome (PCOS) Drugs Segment Market Analysis (by Type)
6.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production by Type
6.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Type
6.3 Polycystic Ovary Syndrome (PCOS) Drugs Price by Type

7 Polycystic Ovary Syndrome (PCOS) Drugs Segment Market Analysis (by Application)
7.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption by Application
7.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Market Share by Application (2014-2019)

8 Polycystic Ovary Syndrome (PCOS) Drugs Major Manufacturers Analysis
8.1 Sanofi
8.1.1 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.1.2 Sanofi Product Introduction, Application and Specification
8.1.3 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis AG
8.2.1 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.2.2 Novartis AG Product Introduction, Application and Specification
8.2.3 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Teva Pharmaceutical Industries Limited
8.3.1 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.3.2 Teva Pharmaceutical Industries Limited Product Introduction, Application and Specification
8.3.3 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Addex Therapeutics Ltd.
8.4.1 Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.4.2 Addex Therapeutics Ltd. Product Introduction, Application and Specification
8.4.3 Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 BIOCAD
8.5.1 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.5.2 BIOCAD Product Introduction, Application and Specification
8.5.3 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Merck KGaA
8.6.1 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.6.2 Merck KGaA Product Introduction, Application and Specification
8.6.3 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 AstraZeneca plc.
8.7.1 AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.7.2 AstraZeneca plc. Product Introduction, Application and Specification
8.7.3 AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bristol Myers Squibb Co.
8.8.1 Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.8.2 Bristol Myers Squibb Co. Product Introduction, Application and Specification
8.8.3 Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Ferring Pharmaceuticals, Inc.
8.9.1 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.9.2 Ferring Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.9.3 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Crinetics Pharmaceuticals, Inc.
8.10.1 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.10.2 Crinetics Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.10.3 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Polycystic Ovary Syndrome (PCOS) Drugs Market
9.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Trend Analysis
9.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Polycystic Ovary Syndrome (PCOS) Drugs Regional Market Trend
9.2.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.3 China Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.4 Japan Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.5 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.6 India Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.3 Polycystic Ovary Syndrome (PCOS) Drugs Market Trend (Product Type)
9.4 Polycystic Ovary Syndrome (PCOS) Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Polycystic Ovary Syndrome (PCOS) Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Polycystic Ovary Syndrome (PCOS) Drugs
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Types in 2018
Figure Oral Contraceptives Product Picture
Figure Antiandrogens Product Picture
Figure Insulin-sensitizing Agent Product Picture
Figure Antidepressant Product Picture
Figure Anti-obesity Product Picture
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Million USD) (2014-2025)
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs) (2014-2025)
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Table Polycystic Ovary Syndrome (PCOS) Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Polycystic Ovary Syndrome (PCOS) Drugs in 2018
Figure Manufacturing Process Analysis of Polycystic Ovary Syndrome (PCOS) Drugs
Figure Industry Chain Structure of Polycystic Ovary Syndrome (PCOS) Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Manufacturing Plants Distribution
Table Polycystic Ovary Syndrome (PCOS) Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Polycystic Ovary Syndrome (PCOS) Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Polycystic Ovary Syndrome (PCOS) Drugs Production Share by Manufacturers in 2018
Table Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Polycystic Ovary Syndrome (PCOS) Drugs Revenue Share by Manufacturers in 2018
Table Polycystic Ovary Syndrome (PCOS) Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Regions 2014-2019
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Regions in 2018
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Regions in 2018
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Market Share by Regions 2014-2019
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Polycystic Ovary Syndrome (PCOS) Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Polycystic Ovary Syndrome (PCOS) Drugs Market Share by Application (2014-2019)
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Polycystic Ovary Syndrome (PCOS) Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Polycystic Ovary Syndrome (PCOS) Drugs by Application (2019-2025)
Table Polycystic Ovary Syndrome (PCOS) Drugs Distributors List
Table Polycystic Ovary Syndrome (PCOS) Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

多嚢胞性卵巣症候群（PCOS）治療薬のグローバル市場調査 2019年

Global Polycystic Ovary Syndrome (PCOS) Drugs Market Professional Survey Report 2019
QYR9NV10204 2019年11月14日 105Pages
※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧...

多嚢胞性卵巣症候群（PCOS）治療法のグローバル市場：規模・現状・予測2019-2025

Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size, Status and Forecast 2019-2025
QYR9NV18299 2019年11月18日 92Pages
※当調査レポートでは、多嚢胞性卵巣症候群（PCOS）治療法の世界市場について調査・分析し、多嚢胞性卵巣症候群（PCOS）治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、排卵誘発剤、...

多嚢胞性卵巣症候群（PCOS）治療法のグローバル市場：規模・現状・予測2019-2025

多嚢胞性卵巣症候群治療のグローバル市場：規模・現状・予測2019-2025

Global Polycystic Ovary Syndrome Treatment Market Size, Status and Forecast 2019-2025
QYR9NV18300 2019年11月18日 91Pages
※当調査レポートでは、多嚢胞性卵巣症候群治療の世界市場について調査・分析し、多嚢胞性卵巣症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニ...

多嚢胞性卵巣症候群治療のグローバル市場：規模・現状・予測2019-2025

骨髄異形成症候群（MDS）治療薬のグローバル市場調査 2019年

Global Myelodysplastic Syndrome (MDS) Therapeutics Market Professional Survey Report 2019
QYR9NV08733 2019年11月14日 107Pages
※本調査レポートは、骨髄異形成症候群（MDS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アザシチジン、レナリドマイド、デシタビン、デフェラシロクス...

急性呼吸窮迫症候群(ARDS)治療薬のグローバル市場調査 2019年

Global Acute Respiratory Distress Syndrome Therapeutics Market Professional Survey Report 2019
QYR9NV00152 2019年11月12日 102Pages
※本調査レポートは、急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サ...

多発性硬化症（MS）治療薬のグローバル市場調査 2019年

Global Multiple Sclerosis (MS) Drugs Market Professional Survey Report 2019
QYR9NV08707 2019年11月14日 111Pages
※本調査レポートは、多発性硬化症（MS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、コパキソン（酢酸グラチラマー、共重合体1）、ノバントロン（ミトキ...

ドライアイ症候群薬のグローバル市場調査 2019年

Global Dry Eye Syndrome Drugs Market Professional Survey Report 2019
QYR9NV03912 2019年11月12日 106Pages
※本調査レポートは、ドライアイ症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、抗生物質ドロップ、ホルモンドロップ、人工涙液、その他に、用途別には、病院...

ギランバレー症候群薬のグローバル市場調査 2019年

Global Guillain-Barre Syndrome Drugs Market Professional Survey Report 2019
QYR9NV05684 2019年11月12日 103Pages
※本調査レポートは、ギランバレー症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Coversin、免疫グロブリン、その他に、用途別には、クリニック、病...

多嚢胞性卵巣症候群（PCOS）治療薬のグローバル市場調査 2019年 The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company …
多嚢胞性卵巣症候群（PCOS）治療法のグローバル市場：規模・現状・予測2019-2025 Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. In 2018, the global Polycystic Ovarian Syndrome (PCOS) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% durin…
多嚢胞性卵巣症候群（PCOS）治療法のグローバル市場：規模・現状・予測2019-2025 Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. In 2018, the global Polycystic Ovarian Syndrome (PCOS) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% durin…
多嚢胞性卵巣症候群治療のグローバル市場：規模・現状・予測2019-2025 Polycystic Ovary Syndrome Treatment means treatment of a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female …
多嚢胞性卵巣症候群治療のグローバル市場：規模・現状・予測2019-2025 Polycystic Ovary Syndrome Treatment means treatment of a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female …